DUBLIN, Dec. 11, 2017 /PRNewswire/ --
The "In Vitro Toxicology Testing Market - Forecast to 2022" report has been added to Research and Markets' offering.
The In vitro toxicology testing market is projected to reach USD 8.74 Billion by 2022 from USD 6.34 Billion in 2017, at a CAGR of 6.6%. The key factors driving the growth of this market include opposition to animal testing, growing demand for in vitro technology in the European market, new and promising technologies, and increasing R&D expenditure to detect toxicity at an early stage.
The report analyzes the global market by products & services, toxicity endpoints and tests, technology, industry, methods, and region.
Based on toxicity endpoints and tests of in vitro toxicology testing, the market is subsegmented into ADME, genotoxicity, skin irritation and sensitization, cytotoxicity, ocular toxicity, organ toxicity, phototoxicity, dermal toxicity, and other toxicities (eco toxicity, endocrine disruption, and reproductive & developmental toxicity). In 2017, the ADME segment is expected to account for the largest share of the global in vitro toxicology testing market owing to its highly reproducible & accurate data and the increasing demand to curb drug toxicity at the drug development phase.
Based on industry, the global market is segmented into pharmaceuticals and biopharmaceuticals, cosmetics & household products, food, and chemicals. In 2017, the pharmaceutical and biopharmaceutical industry segment is expected to account for the largest share of the global market. The new research initiatives, mandatory preclinical safety evaluation of molecules, and growing R&D for detecting toxicity in the early stages of drug development are the primary growth drivers for this industry segment.
Based on region, the in vitro toxicology testing market is segmented into Europe, North America, Asia Pacific, and the RoW. In 2017, Europe is projected to account for the largest share of the global market. The demand for in vitro toxicology testing in Europe is driven by the increasing number of investments in research and innovation by the European Commission to develop alternative methods to animal testing. The European Union has been a leader in supporting research to advance the development and validation of in vitro toxicology testing protocols for regulatory purposes.
- Ascendance Biotechnology, Inc.
- Bio-Rad Laboratories, Inc.
- Catalent, Inc.
- Charles River Laboratories International, Inc.
- Covance, Inc. (A Part of Laboratory Corporation of America Holdings)
- Cyprotex Plc (A Subsidiary of Evotec Ag)
- Eurofins Scientific Se
- Ge Healthcare
- Gentronix Limited
- MB Research Laboratories
- Merck Kgaa
- Promega Corporation
- Qiagen N.V.
- SGS S.A.
- Thermo Fisher Scientific, Inc
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Industry Insights
6 Market Overview
7 In Vitro Toxicology Testing Market, By Product And Service
8 In Vitro Toxicology Testing Market, By Toxicity Endpoints And Tests
9 In Vitro Toxicology Testing Market, By Technology
10 In Vitro Toxicology Testing Market, By Industry
11 In Vitro Toxicology Testing Market, By Method
12 In Vitro Toxicology Testing Market, By Region
13 Competitive Landscape
14 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/vlzb7s/in_vitro
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets